Verona Pharma (VRNA) Earnings Date & Reports

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

VRNA is expected to report earnings to rise 33.40% to -6 cents per share on April 29

Verona Pharma VRNA Stock Earnings Reports

Q1'25

Est.

$-0.07

Q4'24

Beat

by $0.02

Q3'24

Est.

$-0.07

Q2'24

Missed

by $0.06

Q1'24

Missed

by $0.01

The last earnings report on February 27 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 877.22K shares outstanding, the current market capitalization sits at 5.38B.

View a ticker or compare two or three

Compare

VRNA